SeekingAlphaSeptember 17, 2026 at 8:59 AM NYLast Month
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Zilebesiran and the Potential of RNAi Therapeutics for Continuous Blood Pressure Control - Slideshow
2026-09-17. The following slide deck was published by Alnylam Pharmaceuticals, Inc.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: SeekingAlpha
